Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Abbott LaboratoriesMEX:ABT -4.37%81 5-Year Yield-on-Cost % is 4.17 as of Jul. 15, 2026, which is 54% above its 10-year median of 2.71. GuruFocus rates MEX:ABT with a GF Score™ of 81/100 and a GF Value™ of MXN2,295.51 (Significantly Undervalued). Among 327 Medical Devices & Instruments companies, Abbott Laboratories ranks better than 71.56% on this metric.
Abbott Laboratories's yield on cost for the quarter that ended in Mar. 2026 was 4.17.
The historical rank and industry rank for Abbott Laboratories's 5-Year Yield-on-Cost % or its related term are showing as below:
MEX:ABT'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.76 Med: 2.71 Max: 4.47
Current: 4.17
During the past 13 years, Abbott Laboratories's highest Yield on Cost was 4.47. The lowest was 1.76. And the median was 2.71.
MEX:ABT's 5-Year Yield-on-Cost % is ranked better than 71.56% of 327
companies
in the Medical Devices & Instruments industry
Industry Median: 2.33
vs MEX:ABT: 4.17
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Abbott Laboratories 5-Year Yield-on-Cost % Related Terms
MEX:ABT vs SYK, MDT, BSX: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Abbott Laboratories's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Abbott Laboratories (MEX:ABT) has a 5-Year Yield-on-Cost % of 4.17 as of Jul. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Abbott Laboratories and its competitors. This is 54% above median its historical median of 2.71. Over the past decade, Abbott Laboratories' 5-Year Yield-on-Cost % has ranged from 1.76 to 4.47. According to the industry distribution chart, Abbott Laboratories ranks #93 out of 327 companies in the Medical Devices & Instruments industry, placing it in the top 28.4%.
Is Abbott Laboratories' 5-Year Yield-on-Cost % too high?
Abbott Laboratories' current 5-Year Yield-on-Cost % of 4.17 is 54% above median its 10-year median of 2.71. Over the past 10 years, this metric has ranged from a low of 1.76 to a high of 4.47. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.33. Abbott Laboratories' value of 4.17 is 79% above this industry median. Based on the distribution chart, Abbott Laboratories ranks #93 out of 327 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Abbott Laboratories has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' 5-Year Yield-on-Cost % compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #93 out of 327 companies for 5-Year Yield-on-Cost %. This puts Abbott Laboratories in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.33. Abbott Laboratories' value of 4.17 is 79% above this benchmark. Historically, Abbott Laboratories' own 5-Year Yield-on-Cost % has ranged from 1.76 to 4.47 over the past decade. While the company's 10-year median is 2.71 vs. the industry median of 2.33, Abbott Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.33, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current 5-Year Yield-on-Cost % of 4.17 is 79% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current 5-Year Yield-on-Cost % is 4.17, which is 54% above median its own 10-year median of 2.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (MEX:ABT) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN2,295.51, compared to a current price of MXN1,550.00 — trading 32.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 4.17, which is 54% above median its 10-year median of 2.71 and 79% above the Medical Devices & Instruments industry median of 2.33. Abbott Laboratories' overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Abbott Laboratories (MEX:ABT), the current 5-Year Yield-on-Cost % is 4.17 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (MEX:ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of MXN1,550.00 is trading 32.5% below its estimated GF Value™ of MXN2,295.51.
GuruFocus considers Abbott Laboratories to be Significantly Undervalued.
Key valuation signals for MEX:ABT:
5-Year Yield-on-Cost %: 4.17 (54% above median its 10-year median of 2.71)
GF Value™: MXN2,295.51 vs. price of MXN1,550.00 (32.5% below fair value)
Industry Position: 79% above the Medical Devices & Instruments median (#93 of 327)
No single metric tells the full story. See the MEX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
81GF Score
Get the complete analysis for MEX:ABT
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ABT has been successfully added to your 
